BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 18424265)

  • 1. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
    Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
    Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J
    J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological proteome analysis.
    Liu J; Xing X; Huang H; Jiang Y; He H; Xu X; Yuan J; Zhou L; Yang L; Zhuang Z
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):393-400. PubMed ID: 19647757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological immunoreactivity against colon cancer proteome varies upon disease progression.
    De Monte L; Sanvito F; Olivieri S; Viganò F; Doglioni C; Frasson M; Braga M; Bachi A; Dellabona P; Protti MP; Alessio M
    J Proteome Res; 2008 Feb; 7(2):504-14. PubMed ID: 18179166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
    Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
    Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD
    Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis.
    Nakanishi T; Takeuchi T; Ueda K; Murao H; Shimizu A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):15-20. PubMed ID: 16707281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptic epitopes induce high-titer humoral immune response in patients with cancer.
    Fischer E; Kobold S; Kleber S; Kubuschok B; Braziulis E; Knuth A; Renner C; Wadle A
    J Immunol; 2010 Sep; 185(5):3095-102. PubMed ID: 20660712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
    López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R
    Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis].
    Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis.
    Yang F; Xiao ZQ; Zhang XZ; Li C; Zhang PF; Li MY; Chen Y; Zhu GQ; Sun Y; Liu YF; Chen ZC
    J Proteome Res; 2007 Feb; 6(2):751-8. PubMed ID: 17269731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An elongation factor-like protein (EF-Tu) elicits a humoral response in infiltrating ductal breast carcinomas: an immunoproteomics investigation.
    Hamrita B; Nasr HB; Hammann P; Kuhn L; Guillier CL; Chaieb A; Khairi H; Chahed K
    Clin Biochem; 2011 Sep; 44(13):1097-1104. PubMed ID: 21704614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display.
    Pavoni E; Pucci A; Vaccaro P; Monteriù G; Ceratti Ade P; Lugini A; Virdis RA; Cortesi E; De Gaetano A; Panunzi S; Felici F; Minenkova O
    Cancer Detect Prev; 2006; 30(3):248-56. PubMed ID: 16876336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components.
    Taylor DD; Atay S; Metzinger DS; Gercel-Taylor C
    Gynecol Oncol; 2010 Feb; 116(2):213-21. PubMed ID: 19945743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis of human lung squamous carcinoma.
    Li C; Xiao Z; Chen Z; Zhang X; Li J; Wu X; Li X; Yi H; Li M; Zhu G; Liang S
    Proteomics; 2006 Jan; 6(2):547-58. PubMed ID: 16342241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.